Product Description
Overall, the global peripheral IVUS market was valued at over $240 million in 2025. This is expected to increase over the forecast period at a CAGR of 6.9% to reach $383 million by 2032.
The full report suite on the global market for peripheral intravascular ultrasound (IVUS) covers seven geographical regions: North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa. For each region, the report provides market valuation, unit analysis and ASP. Moreover, the report will extend its projections up to the year 2032, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.
This report is part of a larger suite that covers the global market for complex peripheral vascular (PV) devices including PV stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy (IVL) systems, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management and peripheral intravascular ultrasound (IVUS) catheters.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Peripheral Intravascular Ultrasound Market Trends
An ongoing trend in the global IVUS market is the continuous development of high-definition imaging technologies and miniaturized catheter systems, allowing for enhanced visualization of vessel structures and improved navigational capabilities during interventional procedures. This trend is driven by the growing demand for real-time and precise intravascular imaging, enabling clinicians to make more informed decisions, optimize stent placements and enhance overall procedural outcomes, particularly in complex cases.
Global Peripheral Intravascular Ultrasound Market Share Insights
- Philips boasts an extensive peripheral IVUS catheter portfolio featuring various models such as Visions® PV .018, Visions® PV .035, Visions® PV .014P and Visions® PV .014P RX. The company’s Eagle Eye Platinum and Eagle Eye Platinum ST IVUS catheters are versatile for both coronary and peripheral procedures, compatible with Philips’ Core® and Core® Mobile IVUS consoles. The distinct advantage of Philips lies in its phased-array IVUS catheters, which offer improved workflow and simplicity in comparison to rotational IVUS catheters. Philips stands out as the sole provider of a comprehensive IVUS catheter range, encompassing 0.014”, 0.018” and 0.035” peripheral IVUS catheters and showing notable strength in venous indications.
- Boston Scientific ranked second in the peripheral IVUS catheter market in 2025, driven by its OptiCross18® peripheral IVUS catheter compatible with iLab® and POLARIS™ systems. The company excels in peripheral arterial disease (PAD) indications due to its comprehensive peripheral portfolio, including complementary devices. However, Boston Scientific faces challenges in the venous market against Philips due to limited sizing options in its IVUS catheter lineup.
Global Peripheral Intravascular Ultrasound Market Segmentation Summary
- Peripheral IVUS Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
